Breaking News Instant updates and real-time market news.

BPMC

Blueprint Medicines

$84.69

1.65 (1.99%)

15:30
05/24/19
05/24
15:30
05/24/19
15:30

Volatility play opened in Blueprint Medicines as shares add 2% to $84.60

Volatility play opened in Blueprint Medicines as shares add 2% to $84.60. 1K Jun 100 calls bought for $1.50 and 1.5K Jun 70 puts for $1.90. The ratio strangle will create some of the largest open interest positions in the name and captures an American Society of Clinical Oncology (ASCO) Annual Meeting on 5/31.

  • 18

    Jun

BPMC Blueprint Medicines
$84.69

1.65 (1.99%)

01/07/19
PIPR
01/07/19
NO CHANGE
Target $235
PIPR
Overweight
Piper Jaffray views price paid for Loxo by Eli Lilly as fair
Piper Jaffray analyst Tyler Van Buren views the price of $235 per share paid by Eli Lilly (LLY) for Loxo Oncology (LOXO) as fair. The analyst says the price is near the $250-plus he previously thought was achievable in an acquisition scenario for Loxo. Other names in the precision medicine/oncology space that could be up today as a result of the buyout are Agios Pharmaceuticals (AGIO), ArQule (ARQL), Array BioPharma (ARRY), Blueprint Medicines (BPMC), Kura Oncology (KURA), Mirati Therapeutics (MRTX) and others, Van Buren tells investors in a research note. He raised his price target for Loxo Oncology to $235 from $200 and keeps an Overweight rating on the shares.
03/28/19
COWN
03/28/19
NO CHANGE
COWN
Outperform
Blueprint closing gap with Loxo in RET+ tumors, says Cowen
Cowen analyst Marc Frahm said he believes the regulatory updates offered last night by Blueprint Medicines (BPMC) for avapritinib, BLU-667 and BLU-782 are all incremental positives, but he views the new clinical data for BLU-667 as "much more newsworthy." His prior survey of lung cancer physicians and investors to assess what response rate from BLU-667 they would consider competitive to Loxo Oncology's (LOXO) LOXO-292 yielded an average physician response of 59% and average investor response was 62%. Given that Blueprint reported an ORR of 62% within the second-line NSCLC cohort of 34 patients, Frahm think consensus is likely to shift towards BLU-667 capturing a meaningful share of the RET+ market, he tells investors. He keeps an Outperform rating on Blueprint Medicines.
04/03/19
MSCO
04/03/19
INITIATION
Target $112
MSCO
Overweight
Blueprint Medicines initiated with an Overweight at Morgan Stanley
Morgan Stanley analyst David Lebowitz initiated Blueprint Medicines with an Overweight rating and $112 price target, calling avapritinib, the company's s lead asset for the treatment of certain types of gastrointestinal stromal tumors, the key driver of his valuation. Avapritinib is on track to be submitted to the FDA in Q2, which should potentially put the drug on the market by year-end, and data so far show it to be a promising therapy, Lebowitz tells investors. He projects gastrointestinal stromal tumor revenues approaching $600M by 2026.
05/23/19
GSCO
05/23/19
INITIATION
Target $125
GSCO
Buy
Blueprint Medicines assumed with a Buy at Goldman Sachs
Goldman Sachs analyst Salveen Richter assumed coverage of Blueprint Medicines with a Buy rating and $125 price target. The firm previously had a Buy rating on the shares. The analyst recommends owning Blueprint for the near- and long-term growth outlook of its two impending launches, avapritinib for PDGFRalpha D842V mutant/4L gastrointestinal stromal tumors and BLU-667 for RET-altered non-small cell lung cancer. He assumes peak unadjusted global sales of $1.7B.

TODAY'S FREE FLY STORIES

JJSF

J & J Snack Foods

$183.94

-0.28 (-0.15%)

18:07
01/22/20
01/22
18:07
01/22/20
18:07
Initiation
J & J Snack Foods initiated  »

J & J Snack Foods…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 11

    Feb

THS

TreeHouse

$46.83

-0.085 (-0.18%)

18:04
01/22/20
01/22
18:04
01/22/20
18:04
Initiation
TreeHouse initiated  »

TreeHouse assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

  • 17

    Feb

HBM

Hudbay Minerals

$3.41

-0.12 (-3.40%)

18:03
01/22/20
01/22
18:03
01/22/20
18:03
Upgrade
Hudbay Minerals rating change  »

Hudbay Minerals upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

TRQ

Turquoise Hill

$0.68

-0.0221 (-3.15%)

18:02
01/22/20
01/22
18:02
01/22/20
18:02
Upgrade
Turquoise Hill rating change  »

Turquoise Hill upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

STLD

Steel Dynamics

$32.02

0.11 (0.34%)

18:02
01/22/20
01/22
18:02
01/22/20
18:02
Earnings
Steel Dynamics CEO says company 'constructive' regarding NA steel market »

"Based on domestic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

STLD

Steel Dynamics

$32.02

0.11 (0.34%)

18:01
01/22/20
01/22
18:01
01/22/20
18:01
Earnings
Steel Dynamics reports Q4 adjusted EPS 62c, consensus 55c »

Reports Q4 revenue $2.4B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

SQ

Square

$68.74

0.42 (0.61%)

, BITCOIN

Bitcoin

$0.00

(0.00%)

17:59
01/22/20
01/22
17:59
01/22/20
17:59
Hot Stocks
Square introduces Lightning Development Kit tools for Bitcoin wallet developers »

The Square Crypto team…

SQ

Square

$68.74

0.42 (0.61%)

BITCOIN

Bitcoin

$0.00

(0.00%)

GBTC

Bitcoin Investment Trust

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

NVCR

Novocure

$94.80

-0.83 (-0.87%)

17:59
01/22/20
01/22
17:59
01/22/20
17:59
Hot Stocks
NovoCure chairman sells 133,777 ordinary shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

KHC

Kraft Heinz

$30.65

-0.37 (-1.19%)

17:52
01/22/20
01/22
17:52
01/22/20
17:52
Initiation
Kraft Heinz initiated  »

Kraft Heinz initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SQ

Square

$68.74

0.42 (0.61%)

17:50
01/22/20
01/22
17:50
01/22/20
17:50
Periodicals
Square wins U.S patent for crypto-to-fiat payments network, Coindesk says »

Paddy Baker of Coindesk,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

QCRH

QCR Holdings

$41.92

0.13 (0.31%)

17:50
01/22/20
01/22
17:50
01/22/20
17:50
Hot Stocks
Breaking Hot Stocks news story on QCR Holdings »

QCR Holdings higher by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

CPB

Campbell Soup

$48.56

-0.01 (-0.02%)

17:48
01/22/20
01/22
17:48
01/22/20
17:48
Initiation
Campbell Soup initiated  »

Campbell Soup initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAG

Conagra Brands

$32.29

-0.475 (-1.45%)

17:45
01/22/20
01/22
17:45
01/22/20
17:45
Initiation
Conagra Brands initiated  »

Conagra Brands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Feb

AMZN

Amazon.com

$1,887.32

-4.96 (-0.26%)

17:43
01/22/20
01/22
17:43
01/22/20
17:43
Periodicals
U.N. experts demand investigation into alleged Bezos hack, Reuters says »

U.N. special rapporteurs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jan

  • 30

    Jan

  • 10

    Feb

BYND

Beyond Meat

$122.48

-6.76 (-5.23%)

17:43
01/22/20
01/22
17:43
01/22/20
17:43
Initiation
Beyond Meat initiated  »

Beyond Meat assumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAIN

Hain Celestial

$25.48

(0.00%)

17:41
01/22/20
01/22
17:41
01/22/20
17:41
Initiation
Hain Celestial initiated  »

Hain Celestial assumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MKC

McCormick

$172.54

1.34 (0.78%)

17:38
01/22/20
01/22
17:38
01/22/20
17:38
Initiation
McCormick initiated  »

McCormick initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 17

    Feb

POST

Post Holdings

$110.10

-1.805 (-1.61%)

17:38
01/22/20
01/22
17:38
01/22/20
17:38
Initiation
Post Holdings initiated  »

Post Holdings initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 07

    Feb

NOC

Northrop Grumman

$375.48

-2.53 (-0.67%)

17:36
01/22/20
01/22
17:36
01/22/20
17:36
Hot Stocks
Northrop Grumman awarded $217.16M Air Force contract modification »

Northrop Grumman was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

PVBC

Provident Bancorp

$12.40

0.06 (0.49%)

17:36
01/22/20
01/22
17:36
01/22/20
17:36
Hot Stocks
Provident Bancorp subsidiary acquires ResX Warehouse Lending »

Provident Bank has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRBR

BellRing Brands

$22.71

-0.26 (-1.13%)

17:34
01/22/20
01/22
17:34
01/22/20
17:34
Initiation
BellRing Brands initiated  »

BellRing Brands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

GVA

Granite Construction

$26.57

-0.19 (-0.71%)

17:32
01/22/20
01/22
17:32
01/22/20
17:32
Hot Stocks
Granite Construction awarded $14M contract by San Bernardino County »

Granite has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GVA

Granite Construction

$26.57

-0.19 (-0.71%)

17:31
01/22/20
01/22
17:31
01/22/20
17:31
Hot Stocks
Granite Construction awarded $14M interesection improvement project in SC »

Granite has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDLZ

Mondelez

$55.47

-0.1 (-0.18%)

17:31
01/22/20
01/22
17:31
01/22/20
17:31
Initiation
Mondelez initiated  »

Mondelez initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 17

    Feb

BFRA

Biofrontera

$10.89

(0.00%)

17:30
01/22/20
01/22
17:30
01/22/20
17:30
Syndicate
Breaking Syndicate news story on Biofrontera »

Biofrontera files $100M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.